Researchers discovered that mutations in the KMO gene cause a rare form of NAD deficiency, a condition where the body cannot produce enough of a critical molecule needed for health. According to Gram Research analysis of a 2026 study, mice with KMO mutations developed birth defects and had significantly lower NAD levels when their mothers consumed limited vitamin B3 during pregnancy. This gene-by-environment interaction suggests that adequate vitamin B3 intake during pregnancy may help prevent birth defects in the rare individuals who carry this mutation.
Researchers discovered that mutations in a gene called KMO can cause a rare condition where the body cannot make enough NAD, a vital molecule needed for health. According to Gram Research analysis, this deficiency becomes especially dangerous when mothers don’t get enough vitamin B3 during pregnancy. Scientists studied this by creating mice with the same genetic mutation and found that when these mice didn’t get enough vitamin B3, their babies were more likely to be born with birth defects and had dangerously low NAD levels. This discovery opens new doors for understanding and potentially preventing certain birth defects.
Key Statistics
A 2026 research study identified two sisters with KMO gene mutations who had elevated metabolites and low NAD levels in their blood, establishing KMO deficiency as a novel cause of congenital NAD deficiency disorder.
In laboratory mice with KMO mutations, a significantly higher proportion of embryos developed birth defects when mothers consumed limited vitamin B3 during pregnancy compared to normal littermates, with affected embryos showing substantially lower NAD levels.
Mice with KMO mutations remained viable and fertile on standard laboratory diet but exhibited elevated serum kynurenine levels and functional dependence on vitamin B3, demonstrating a critical gene-by-environment interaction.
Chemical analysis of affected KMO-deficient embryos revealed that NAD deficiency disrupted multiple metabolic pathways including pyrimidine, purine, and pentose phosphate pathways essential for normal fetal development.
The Quick Take
- What they studied: Whether mutations in the KMO gene can cause a rare condition where the body cannot produce enough NAD, a critical molecule for health, especially when vitamin B3 intake is low.
- Who participated: Two sisters with birth defects and genetic mutations in the KMO gene, plus laboratory mice bred to have the same genetic mutation to study how the condition develops.
- Key finding: Mice with KMO mutations developed birth defects and had significantly lower NAD levels when their mothers consumed limited vitamin B3 during pregnancy, compared to normal littermates.
- What it means for you: This research suggests that pregnant people with this rare genetic mutation may need to ensure adequate vitamin B3 intake to reduce the risk of birth defects in their babies. However, this applies only to the very small number of people with KMO mutations, which is extremely rare.
The Research Details
Researchers identified two sisters with birth defects who both carried mutations in the KMO gene, a gene that helps control how the body processes certain amino acids and produces NAD. To understand how this genetic mutation causes problems, they created laboratory mice with the same KMO gene mutation. The scientists then tested these mice under different conditions, including varying levels of vitamin B3 in their diet, to see how the mutation affected development and NAD production. They also analyzed the chemical makeup of embryos from these mice to understand which biological pathways were disrupted.
This approach, called a gene-by-environment study, is powerful because it shows how a genetic problem only becomes harmful under certain environmental conditions. In this case, the KMO mutation only caused serious problems when vitamin B3 was scarce. The researchers used advanced chemical analysis to measure NAD levels and identify which metabolic pathways were affected.
Understanding how genetic mutations interact with diet is crucial for preventing birth defects. This research shows that some genetic conditions can be managed or prevented through proper nutrition during pregnancy. By identifying KMO as a new cause of NAD deficiency, doctors can now test for this mutation in families with unexplained birth defects and potentially recommend vitamin B3 supplementation as a preventive measure.
This study has both strengths and limitations. The strength is that researchers confirmed their findings in both human patients and animal models, which increases confidence in the results. The limitation is that only two human patients were identified, so the full range of how this mutation affects people is not yet known. The study was published as a preprint, meaning it has not yet undergone full peer review by other scientists, though the methodology appears sound.
What the Results Show
The two sisters with KMO mutations had elevated levels of certain metabolites (chemical byproducts) in their blood and low NAD levels in their plasma, the liquid part of blood. This pattern matched what researchers expected to see if the KMO gene was not working properly. When scientists created mice with the same KMO mutation, the mice survived and could reproduce normally when eating standard laboratory food. However, these mice had higher levels of kynurenine, a chemical that builds up when KMO is not functioning.
The critical finding emerged when researchers limited vitamin B3 in the diet of pregnant mice with the KMO mutation. Under these conditions, a significantly higher proportion of embryos developed birth defects compared to normal embryos. Additionally, these affected embryos had much lower NAD levels than their normal littermates. The researchers measured NAD levels directly and found the difference was substantial and statistically significant.
Chemical analysis of the affected embryos revealed that NAD deficiency disrupted multiple important metabolic pathways, including those that build DNA and RNA (the genetic instructions for cells) and those that produce energy. This suggests that NAD deficiency during development interferes with the basic processes needed for normal fetal growth.
The research showed that mice with KMO mutations could function normally on a regular diet, suggesting that the mutation only causes problems under specific conditions. This finding is important because it explains why some people with genetic mutations never develop symptoms. The study also revealed that the body’s ability to compensate for the KMO mutation depends heavily on having enough vitamin B3 available. When vitamin B3 is adequate, the body can produce enough NAD through alternative pathways. When vitamin B3 is scarce, these backup systems fail.
Before this research, scientists knew that NAD deficiency disorders could be caused by mutations in three other genes: KYNU, HAAO, and NADSYN1. All of these genes are involved in the kynurenine pathway, a series of chemical reactions that help the body process amino acids and produce NAD. This study adds KMO as a fourth gene that, when mutated, can cause NAD deficiency. The pattern is consistent with previous research showing that disruptions anywhere in the kynurenine pathway can lead to serious health problems. This research also reinforces the importance of gene-by-environment interactions, where a genetic problem only manifests when environmental conditions are unfavorable.
The study identified only two human patients, so the full range of symptoms and severity in people with KMO mutations is unknown. The research was conducted in mice, and while mouse models are valuable, results do not always translate directly to humans. The study did not test whether vitamin B3 supplementation could actually prevent birth defects in the affected mice, though the evidence strongly suggests it might. Additionally, the study was published as a preprint and has not yet undergone formal peer review by other scientists, though the methodology appears rigorous.
The Bottom Line
For the extremely rare individuals with KMO mutations, this research suggests that ensuring adequate vitamin B3 intake during pregnancy may help prevent birth defects. Pregnant people should consult with their doctor about vitamin B3 supplementation if they carry this mutation. For the general population, this research does not change current recommendations, as KMO mutations are extremely rare. Standard prenatal vitamin recommendations already include adequate vitamin B3.
This research is most relevant to families with a history of unexplained birth defects who may carry KMO mutations. Genetic counselors and doctors who work with families affected by congenital anomalies should be aware of this new genetic cause. The general public should understand that this is a rare condition affecting a tiny fraction of the population. People without known genetic mutations do not need to change their vitamin B3 intake based on this research.
If this research leads to clinical interventions, benefits would likely appear during pregnancy, with reduced birth defect rates in future pregnancies of affected individuals. The timeline from this discovery to clinical application typically takes several years as researchers conduct additional studies and develop testing protocols.
Frequently Asked Questions
What is KMO and why does it matter for birth defects?
KMO is a gene that helps your body produce NAD, a molecule essential for cell energy and development. When KMO is mutated, the body struggles to make enough NAD, especially during pregnancy when vitamin B3 is limited, increasing the risk of birth defects.
Do I need to worry about KMO mutations if I’m planning to get pregnant?
KMO mutations are extremely rare. Unless you have a family history of unexplained birth defects or have been genetically tested, you almost certainly do not carry this mutation. Standard prenatal vitamins already contain adequate vitamin B3 for most people.
Can vitamin B3 supplementation prevent birth defects caused by KMO mutations?
Research in mice suggests that adequate vitamin B3 during pregnancy may help prevent birth defects in individuals with KMO mutations. However, human studies have not yet confirmed this. Anyone with a confirmed KMO mutation should work with their doctor to determine appropriate vitamin B3 levels.
What foods are high in vitamin B3 for pregnancy?
Excellent sources include chicken, turkey, tuna, peanuts, mushrooms, and fortified cereals. Most prenatal vitamins also contain vitamin B3. Aim for 14-16 mg daily during pregnancy, or higher if recommended by your healthcare provider.
How would I know if I have a KMO mutation?
Genetic testing is required to identify KMO mutations. This is typically recommended only for families with unexplained birth defects or congenital anomalies. Talk to a genetic counselor or your doctor if you have concerns about your family history.
Want to Apply This Research?
- For users with confirmed KMO mutations, track daily vitamin B3 intake in milligrams and correlate with any symptoms or health markers. Set a daily goal of 14-16 mg for women based on current recommendations and work with a healthcare provider to determine if higher doses are needed.
- Users identified with KMO mutations should use the app to log vitamin B3-rich foods including chicken, tuna, turkey, peanuts, mushrooms, and fortified cereals. Set reminders for prenatal vitamin intake if planning pregnancy, and log any symptoms or health concerns to share with their healthcare provider.
- Establish a baseline of current vitamin B3 intake, then gradually increase to recommended levels while monitoring energy levels and any changes in symptoms. For pregnant users with this mutation, maintain consistent tracking throughout pregnancy and work with healthcare providers to monitor NAD levels through blood tests if available.
This research describes a rare genetic condition affecting a very small population. This article is for educational purposes and should not be considered medical advice. If you have a family history of unexplained birth defects, congenital anomalies, or suspect you may carry a genetic mutation, consult with a genetic counselor or healthcare provider for personalized evaluation and testing. Pregnant individuals should follow their healthcare provider’s recommendations for prenatal vitamins and nutrition. Do not change vitamin supplementation without consulting your doctor, especially during pregnancy.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.